Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Anika Therapeutics buy Barrington Research

Start price
€23.40
09.05.24 / 50%
Target price
€34.32
09.05.25
Performance (%)
0.85%
Price
€23.60
31.05.24
Summary
This prediction is currently active. Since the start of the prediction for Anika Therapeutics the price has only changed by 0.85%. This prediction currently runs until 09.05.25. The prediction end date can be changed by Barrington_Research at any time. Barrington_Research has 50% into this prediction
Performance without dividends (%)
Name 1w
Anika Therapeutics 4.425%
iShares Core DAX® -0.552%
iShares Nasdaq 100 -1.415%
iShares Nikkei 225® -0.877%
iShares S&P 500 -0.415%

Comments by Barrington_Research for this prediction

In the thread Anika Therapeutics diskutieren
Prediction Buy
Perf. (%) 0.85%
Target price 34.318
Change
Ends at 09.05.25

Anika Therapeutics, Inc. (NASDAQ: ANIK) had its "outperform" rating re-affirmed by analysts at Barrington Research. They now have a $37.00 price target on the stock.
Ratings data for ANIK provided by MarketBeat

Stopped prediction by Barrington_Research for Anika Therapeutics

buy
Anika Therapeutics

Start price
Target price
Perf. (%)
€20.60
03.01.24
€26.58
03.01.25
14.56%
31.05.24

buy
Anika Therapeutics

Start price
Target price
Perf. (%)
€19.70
03.11.23
€26.08
03.11.24
19.80%
31.05.24

buy
Anika Therapeutics

Start price
Target price
Perf. (%)
€18.10
14.08.23
-
14.08.24
30.39%
31.05.24